Tag: Vascular access

UK survey highlights access cannulation experiences and importance of patient-staff discussions

A regional patient survey from the UK has revealed a 71% rate of good experiences with vascular access cannulation, and a “great appreciation” for...

Setting clear expectations early on is an important step in the...

Stephen Hohmann (Texas Vascular Associates, Dallas, USA) recently sat down with Renal Interventions to discuss a number of key considerations along the dialysis journey,...

Standardised definitions are required before frailty can be routinely assessed in...

Earlier this year, a retrospective study published in the American Journal of Kidney Diseases came to the conclusion that “frailty may be useful for...

Gore acquires InnAVasc Medical

Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease...

Fistula, graft or catheter—first and foremost, dialysis patients want an access...

“Catheters are not nearly as bad as we make them out to be.” This was one of the salient messages delivered by Theodore Saad...

EVA meeting harnesses global, multidisciplinary experts and analysis to guide the...

Lively discussion on unmet needs and building on quiet developments in vascular access from leading surgeons, interventional radiologists, nephrologists and interventional nephrologists formed the...

N-PATH provides valuable opportunity for dedicated, modular interventional nephrology training

 Monnie Wasse, past-president of the American Society of Diagnostic and Interventional Nephrology (ASDIN) and director of interventional nephrology at Rush University Medical Centre (Chicago,...

KDOQI guidelines: Much-needed overhaul and missed opportunities

Scott Trerotola (University of Pennsylvania, Philadelphia, USA), who is set to be awarded a Society of Interventional Radiology (SIR) Gold Medal in June 2022,...

Flex Vessel Prep system demonstrates favourable six-month results compared to historical...

New data presented at the 2022 Vascular Access for Hemodialysis Symposium (9–11 June, Charleston, USA) have demonstrated favourable outcomes with the Flex Vessel Prep...

Matteo Tozzi

Having grown up and studied medicine in Rome, Matteo Tozzi is currently deputy head of the Department of Medicine and Surgery, and associate professor...

Save Your Vein: Transforming venous preservation from hope into reality

Jeremy Crane (London, UK) discusses the topic of vein preservation—including its central importance to successful dialysis access creation, and practical measures for achieving it...

Sirogen™: A potential solution for improving arteriovenous fistula maturation

This advertorial is sponsored by Vascular Therapies Arteriovenous fistula (AVF) maturation is a pivotal event in patients requiring haemodialysis. Maximising the number of fistulas that...

Pharmacological approaches to reducing arteriovenous fistula failure rates

Sanjay Misra (Rochester, USA) discusses the need for pharmacological approaches that can improve successful, long-term outcomes with arteriovenous fistulas (AVFs) and outlines a handful...
vascular access frailty

Increased frailty associated with longer time to functional use of vascular...

A retrospective analysis of the US Renal Data System has found that, in patients undergoing haemodialysis treatment, a higher degree of frailty is associated...

Nipro to bring Cronus high-pressure PTA balloon catheter to USA

Nipro Medical Corporation is set to introduce its second-generation Cronus high-pressure (HP) percutaneous transluminal angioplasty (PTA) balloon catheter to the US market. Cronus HP is...

Charmaine Lok

Equally at home on the ward seeing patients, at study sites conducting research, and travelling the world for voluntary medical missions, Charmaine Lok has...

Houston, we have a dialysis access problem

The concept of dedicated vascular access centres fuels a turbocharged Texan tussle with Karl Illig (Flow Vascular Center, Houston, USA) taking on Eric Peden...

PatenSee’s contactless imaging device demonstrates promise in timely and accurate monitoring...

The interim results of an ongoing clinical study of PatenSee's contactless imaging device for the early detection of vascular access stenosis in dialysis patients...

CX returns to in-person format once more in the London spring

Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...
haemodialysis patients cannulation

Systematic review sheds light on “unpleasant necessity” of cannulation for haemodialysis...

A systematic review published in the Journal of Vascular Access (JVA) has illuminated haemodialysis patients’ views and experiences of arteriovenous access cannulation, concluding that...

Experimental gel shows promise in aiding creation and development of arteriovenous...

Researchers from the University of Alabama at Birmingham (UAB; Birmingham, USA) and US firm Endomimetics are working to develop a long-sought-after, effective therapy that...
haemodialysis patients cannulation

Study indicates lower wound infection and surgical reintervention rates in pAVF...

A single-centre, retrospective, comparative study, which was presented at the July 2021 Journal of Vascular Surgery (JVS) Journal Club (14 July, online), has found...

Sweeping technological advances enable interventional radiologists to close in on crucial...

 Nicholas Inston (consultant vascular access and renal transplant surgeon, Birmingham, UK) discusses the crucial care interventional radiologists provide for renal patients with Ian Mcafferty...

CX 2022: Nicholas Inston on Vascular Access Challenges

 Nicholas Inston (Birmingham, UK) talks to CX about the challenges in creation, maintenance and salvage of vascular access in patients with end stage renal disease....

Ellipsys™ Vascular Access System provides consistently great outcomes for AV fistula...

 Alexandros Mallios (Paris, France) and Robert Shahverdyan (Hamburg, Germany) talk to Vascular News about some of the benefits of the Ellipsys™ Vascular Access System...
alio

Alio and Lifeline create partnership for dialysis access patient monitoring

Alio has announced a partnership with Lifeline Vascular Care in support of patients living with end-stage renal disease (ESRD). Alio leverages artificial intelligence (AI)...
amplifi artio

Amplifi vein dilation system demonstrates “encouraging” clinical results in haemodialysis access

Artio Medical has announced that full results from its first-in-human clinical study of the Amplifi vein dilation system were presented at the 2021 VEITHSymposium...
vascular access handbook gemav

New vascular access handbook intends to provide dialysis patients with answers...

At the 12th Congress of the Vascular Access Society (VAS; 6–9 April 2021, online), Ramon Roca-Tey, senior consultant in nephrology at the Fundación Sanitaria...
global kidney disease guidelines

PVI 2021: Global standardisation of guidelines and patient-first approach to kidney...

In the future, a global approach to help standardise clinical practice guidelines for kidney disease may be the ideal way forward. This was the...
dialysis

Stable incidence and survival of AVFs seen in long-term study of...

Despite an older dialysis population, the proportion and survival of arteriovenous fistulas (AVFs) in Danish dialysis patients has not changed over a 39-year period....
amplifi artio

Results from first-in-human study of Amplifi vein dilation system presented at...

Preliminary clinical results from a first-in-human study assessing the Amplifi vein dilation system (Artio Medical) were presented at this year’s Vascular InterVentional Advances conference (VIVA;...
oversized balloon angioplasty

Oversized balloon angioplasty technique safe and effective for AV fistula maturation

A retrospective analysis published in the Journal of Vascular Access (JVA) has shown that the oversized balloon angioplasty technique to assist arteriovenous (AV) fistula...

A new ERA: The umbrella association seeking to speak with one...

 Nicholas Inston (Queen Elizabeth Hospital Birmingham, Birmingham, UK), secretary of the Vascular Access Society (VAS) and chairman of the editorial board for Renal Interventions interviews Christoph...

Does anaesthetic technique during AV fistula creation influence long-term successful outcomes?

The largest randomised controlled trial comparing long-term surgical outcomes between two different anaesthetic techniques, the ACCESs study, has just launched in the UK, to...
treating steal syndrome

Treating steal syndrome: Symptoms, flow rate and anastomosis location all key...

When it comes to treating steal syndrome, the extent to which the dialysis patient in question is displaying symptoms—as well as their flow rate...
new vascular access technologies

Nitric oxide, simulation and “living” grafts: Is the landscape of vascular...

The field of vascular access care for haemodialysis patients may look very different in just a few years’ time, with a host of new,...
early-cannulation grafts

Early-cannulation grafts display parity with ePTFE options—but also face similar challenges

In addition to demonstrating comparable performance in terms of long-term patency, durability and associated complications, early-cannulation arteriovenous (AV) grafts may hold some advantages when...
sabine nipshagen plastic cannulas

Plastic cannulas offer useful new option in toolbox for renal nurses

Despite currently being less commonly used than metal needles in haemodialysis access, particularly in Europe, plastic cannulas offer a “useful new tool in the...
av graft surveillance david kingsmore

Treating venous stenosis: Experts agree re-evaluation of AV graft surveillance is...

In its current form, postprocedural surveillance of arteriovenous grafts (AVGs) used to treat venous stenosis is “little more than supervised neglect”, and should be...
high flow av fistulas

High-flow fistulas remain divisive, with uncertainty over reduction and outcomes

Discussions at this year’s Charing Cross (CX) 2021 Digital Edition (19–22 April, online) indicated that high-flow arteriovenous (AV) fistulas remain one of the more...

Vascular Therapies announces clinical results from phase 3 randomised multicentre clinical...

Vascular Therapies recently announced results from its phase 3 clinical trial in which Sirogen showed encouraging arteriovenous fistula (AVF) outcomes in elderly end-stage renal...

LINC 2021: Positive first-time data presented for IN.PACT AV DCB and...

New data presented for the first time at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) support the use of drug-coated balloons (DCBs)...

Dialysis access needs to be a priority in the COVID-19 era

Panagiotis M Kitrou and Nicholas Inston discuss the impact of the COVID-19 pandemic on vascular access services. Despite the disruption caused, they are optimistic...

CX 2020 LIVE: Vascular Access session showcases new technologies, while debate...

The CX 2020 LIVE Vascular Access Consensus session sparked global interest, with chair Nick Inston (Birmingham, UK) and moderator Domenico Valenti (London, UK) taking...

“More creative solutions” needed for end-stage vascular access patients

Nicholas (Nick) Inston calls for “more creative solutions” to vascular access challenges, commending interventional radiologists’ innovative reputation as instrumental to increasing the number of...